Levine Mark S.
SEC-identified person · CIK 1617236 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| 908 Devices Inc. MASS | Chief Legal and Admin. Officer | filed 2026–2026 |
| Immunovant, Inc. IMVT | Chief Legal Officer | filed 2022–2024 |
| Flexion Therapeutics Inc FLXN | SVP & General Counsel | filed 2017–2021 |
| Minerva Neurosciences, Inc. NERV | Vice President,General Counsel | filed 2014–2017 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.